View Older Articles
Illinois Supreme Court Decision Impacts the Use of Canines
Recent Illinois Supreme Court case handed down last week, impacts the use of K-9s.
Law Enforcement is now required to obtain a search warrant before they can use a narcotics dog in the common areas of apartment complexes. Agencies should confer with their prosecutor's offices for more direction.
Executive Institute Newsletter- October 2017
Executive Institute October Newsletter
This edition of ILETSBEI news features the Recommendations on Selection and Use of Personal Protective Equipment and Decontamination Products for First Responders Against Exposure Hazards to Synthetic Opioids, Including Fentanyl and Fentanyl Analogues by the Interagency Board.
Fighting the Opioid Crisis through Substance Use Disorder Treatment by ICJIA
Fighting the Opioid Crisis through Substance Use Disorder Treatment: A Study of a Police Program Model in Illinois
Illinois Criminal Justice Information Authority
Seeking to more effectively help individuals suffering from opioid use disorder, police departments across the country are embracing a deflection model that offers treatment access to those in need. Researchers interviewed representatives of seven law enforcement agencies employing treatment program models in Illinois to better understand operations, leverage lessons learned, measure sustainability, and inform other agencies as they implement their own programs.
Addressing the Elephant in the Room
From Bruce Talbot
Addressing the Elephant in the Room
The U.S. Drug Enforcement Administration announced on August 30, 2017 a major initiative to address Carfentenil abuse. Carfentenil, widely called "elephant tranquilizer" in media reports is an incredibly potent synthetic narcotic used on zoo animals.
Grant Funding for NARCAN
GRANT FUNDING AVAILABLE FOR NARCAN
First Responders? Comprehensive Addiction and Recovery Act Cooperative Agreement (CFDA No. 93.243)
Purpose: To allow first responders and members of other key community sectors to administer a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose.
Fentanyl: What first responders need to know about this potentially lethal drug
Fentanyl: What first responders need to know about this potentially lethal drug
By Shane W. Fitzpatrick, ACP - Tactical, Tactical Emergency Medical Support, Emergency Medical Services, Calgary Metro Alberta Health Services, IPSA TEMS Committee Chair
The illegal use of fentanyl is quickly becoming a public health crisis in Northern America – specifically Canada and United States. As a paramedic working the front lines on Calgary streets, I am seeing more and more fentanyl overdoses leading to respiratory and cardiac arrest.
This drug is not only affecting the drug users but poses an exposure risk to first responders. Public safety workers need to be educated and protected by protocols and Personal Protective Equipment (PPE).
NATIONAL AND ILLINOIS YOUTH SUBSTANCE USE: RISK FACTORS, PREVALENCE, AND TREATMENT
Illinois Criminal Justice Information Authority During stages of ongoing, yet incomplete, cognitive development, youth may be more inclined to take risks and experiment with drugs and alcohol and are often heavily influenced by their peers, leading to negative outcomes. Nationally and in Illinois, traditionally high drug use categories of marijuana and alcohol appear to be stable or falling and youth use of other drugs remains relatively low. READ MORE
DEA Schedules Deadly Synthetic Drug U-47700
FOR IMMEDIATE RELEASEContact: DEA National Media Affairs(202) 307-7977@DEAHQPress ReleaseDEA Schedules Deadly Synthetic Drug U-4770046 confirmed deaths linked to dangerous opioid in '15 and '16 sparks emergency actionWASHINGTON, DC Responding to the imminent threat to public health and safety, the U.S. Drug Enforcement Administration (DEA) has placed U-47700 into Schedule I of the Controlled Substances Act, effective on November 14th. Emergency scheduling of dangerous drugs such as U-47700 on a temporary basis is one of the most significant tools DEA can utilize to address the problems associated with deadly new street drugs.DEA has received reports of at least 46 confirmed fatalities associated with U-47700. 31 of those fatalities occurred in New York and 10 in North Carolina. From October 2015 to September 2016, DEA has received 88 reports from State and local forensic laboratories of U-47700 submissions.This scheduling action will last for 24 months, with a possible 12-month extension if DEAneeds moredata to determine whether it should be permanently scheduled.U-47700 is a novel synthetic opioid, and its abuse parallels that of heroin, prescription opioids, and other novel opioids. Law enforcementagencies reportseizures of the drugin powder form and counterfeit tablets that mimic pharmaceutical opioids.Abuse of the drug often happens unknowingly to the user, and is encountered as a single substance as well as in combination with other drugs such as heroinandfentanyls. Som
Resource Reminder- Illinois Medical Cannabis Program Resource Page
On November 30, 2015 MTU1 first posted a resource page of Illinois Medical Cannabis Pilot Program Information.The State of Illinois has approved a number of Medical Marijuana Dispensaries to begin selling marijuana. The resource page supplies some useful links for the approved medical cannabis pilot programThe resourcepage contains the following information IllinoisMedicalCannabisPilotProgramUsefulWebLinks Sample Identification Cards and Shipping Manifest Illinois Vehicle Code violation for Possession of medical cannabis in a motor vehicle Refer Questions about: Patients/Caregivers, CultivationCenters,Dispensaries The page isrestricted to Law Enforcement personnel with a username/password.GO toMedical Cannabis resource page Illinois Vehicle Code(625 ILCS 5/11-502.1) Sec. 11-502.1. Possession of medical cannabis in a motor vehicle.(a) No driver, who is a medical cannabis cardholder, may use medical cannabis within the passenger area of any motor vehicle upon a highway in this State.(b) No driver, who is a medical cannabis cardholder, a medical cannabis designated caregiver, medical cannabis cultivation center agent, or dispensing organization agent may possess medical cannabis within any area of any motor vehicle upon a highway in this State except in a sealed, tamper-evident medical cannabis container.(c) No passenger, who is a medical cannabis card holder, a medical cannabis designated caregiver, or medical cannabis dispensing organization agent may possess medical
Appelate Court Decision: All This in One Case! -Informants, P.C. for Traffic Stops, Consent Searches, Someone Elses Car, Temporary Detention, Handcuffing, Dog Sniffs & Terry Stops O'My!
Appellate Case Posted 10-7-16Search and Seizure: Reversed and remanded:The fourth amendment requires more than some minimal level of objective justification for making a Terry stop. However, independent corroboration of significant aspects of an informant's predictions can impart a degree of reliability on the informant's other allegations sufficient to support an investigative stop. Fourth amendment guarantees are not implicated when police conduct a search pursuant to a voluntary consent. An individual who does not have a possessory interest in a vehicle cannot challenge the search of either the exterior or the interior of the car.No. 2016 IL App (1st) 152678 People v. Duran (weblink) Filed 10-7-16 (ATH)The defendant was charged with one count of possession with intent to deliver 900 grams or more of methamphetamine. The defendant filed a motion to quash arrest his arrest and suppress evidence arguing the search of the car in which he was riding as well as his bag where the methamphetamine was found was done without consent, articulable factual justification or probable cause. The trial court granted defendant's motion after a hearing finding defendant was arrested without probable cause and therefore the seizure of the methamphetamine was unlawful. The appellate court reversed the trial court's order granting the motion to quash arrest and suppress evidence.FINAL Paragraphs after going through all of the hoops!! 36 In this case, the Cadillac in which the defendant was ridi
DEA Reduces Amount of Opioid Controlled Substances to be Manufactured in 2017
Press ReleaseDEA Reduces Amount of Opioid Controlled Substancesto be Manufactured in 2017WASHINGTON, DC The United States Drug Enforcement Administration (DEA) has reduced the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the United States in 2017 by 25 percent or more, accordingto a Final Order being published in the Federal Register tomorrow and available for public inspection today here. A handful of medicines were reduced by more, such as hydrocodone, which will be 66 percent of last year's level. Demand for these opioid medicines, represented by prescriptions written by DEA-registered practitioners, has decreased according to sales data obtained by DEA from IMS Health, a company that provides insurance companies with data on prescriptions written and prescription medications sold in America.The Aggregate Production Quota (APQ) established by the Final Order is the total amount of a controlled substance necessary to meet the estimated medical, scientific, research, industrial,and export needs for the year and for the maintenance of reserve stocks. The 2017 APQ has been reduced for oxycodone, hydrocodone, fentanyl, hydromorphone, morphine, and other such medications. Much of this reduction is attributed to the elimination of a 25 percent buffer that was added to the APQ annually in 2013 through 2016 to guard against shortages.The 2015 National Survey on Drug Use and Health (NSDUH) released last month found 6.5 million American
DEA Announces Intent to Schedule Kratom
For immediate release -August 30,2016Contact DEA Public Affairs (202) 307-7977Washington, DC The Drug Enforcement Administration (DEA) today announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety.Mitragynine and 7-hydroxymitragynine are found in kratom, which is a tropical tree indigenous to Thailand, Malaysia, Myanmar, and other areas of Southeast Asia. The announcement was made in the U.S. Federal Register and can be found here.Kratom is abused for its ability to produce opioid-like effects and is often marketed as a legal alternative to controlled substances. Law enforcement nationwide has seized more kratom in the first half of 2016 than any previous year and easily accounts for millions of dosages intended for the recreational market, according to DEA findings. In addition, kratom has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and has a lack of accepted safety for use under medical supervision. These three factors constitute a Schedule I controlled substance according to the Controlled Substances Act passed by Congress in 1970.Kratom has been seized by law enforcement in various forms, including powder, plant, capsules, tablets, liquids, gum/resin, and drug patch. Because the identity, purity levels, and quantity of these substances are uncertain and inconsistent, they pose significant adverse
UPDATED: Opioid medication-assisted treatment program funding opportunity
UPDATED NOTICE OF FUNDING OPPORTUNITY -New grant eligibility requirements-New mandatory webinar dateLocal Jail Comprehensive Opioid Medication-Assisted Treatment Program GrantsThe Illinois Criminal Justice Information Authority is requesting applications for federal Residential Substance Abuse Treatment Program and Edward Byrne Memorial Justice Assistance Grants to implement a local jail comprehensive opioid medication-assisted treatment program. A total of $694,575 is available for this funding opportunity.For application materials and other information, including updated eligibility requirements, go to:www.icjia.state.il.us/opioidnofoParticipation in a MANDATORY webinar on Wednesday, September 7, 2016, is required of all applicants.Register for mandatory webinarApplicationdeadline:October 3, 2016
DEA Announces Actions Related to Marijuana and Industrial Hemp
AUG 11 (WASHINGTON) - The Drug Enforcement Administration (DEA) announced several marijuana- related actions, including actions regarding scientific research and scheduling of marijuana, as well as principles on the cultivation of industrial hemp under the Agricultural Act of 2014.DEA Publishes Responses to Two Pending Petitions to Reschedule MarijuanaDEA has denied two petitions to reschedule marijuana under the Controlled Substances Act (CSA).READ ARTICLE
Notice of funding opportunity: Opioid Medication-Assisted Treatment
2016 Comprehensive Opioid Medication Assisted Treatment Program Notice of Funding OpportunityThe Illinois Criminal Justice Information Authority is requesting applications for federal Residential Substance Abuse Treatment Program and Justice Assistance Grants to implement a comprehensive opioid medication-assisted treatment (MAT) program for justice-involved persons. A total of $694,575 is available for this funding initiative. The application deadline is October 3, 2016. Participation in a MANDATORY webinar on August 26, 2016, is required of allapplicants.The MAT program hasthreecomponents: Jail-based substance abuse treatment including Cognitive Behavioral Therapy(CBT). Pre- and post-release case management and MAT substance abuse treatmentservices. Probationsupervision.The three components must work in coordination to identify opioid-addicted jail detainees at high risk of reoffending through validated screening and assessment. Offenders identified for program participation must be provided jail-based substance abuse treatment and linked to transitional case management services and community-based MAT services for opioid addiction, including the administration of long-acting Vivitrol. Case management and community-based substance abuse treatment staff will work in coordination with probation officers to monitor offender progress and compliance with monthly MATadministration.Eligibility:This solicitation is open to Illinois counties that are not eligible for direct JAG l
SB2228- How Do I Get Quantitative Testing Done?
MTU1 is receiving inquiries about the significant operational effects resulting from SB2228 andhas scheduled a Legislative Update- Effects from Modification of Cannabis Control Act inFreeport on September 1, 2016.Although drug testing is not per-say a training issue, one of the obvious questions will be about where an agency can get quantitative testing for THC levels in blood. On July 29, 2016 the Illinois State Police notified everyone that it was not set up for this testing and it "will take a significant amount of time" to be authorized to conduct this testing.The ISP toxicology program manager indicates he is only aware of one company in the United States who is ISO-IEC-17025 compliant for this test at the present time, but some unknown laboratories may be working on it. MTU1 made some inquiries and has come up with the same conclusion.MTU1 is not recommending any certain company, but it appears "National Medical Services" (NMS)at this present time is the only US company ISO-IEC-17025 compliant for this test.For more information about National Medical Services, you may contact field representative Eric White at 215-205-1359 or firstname.lastname@example.org. Eric indicated that in two weeks the company will have made necessary adjustments for testing samples from the State of Illinois with an approximate 2 week turn around.Part of the July 29, 2016 information from the ISP lab stated:The second key provision of this legislative bill establishes an intoxication level of tetrahydr
Illinois State Police releases briefing after governor signs marijuana decriminalization bill
On Friday July 29, 2016 Governor Bruce Raunersigned SB2228, which amends the Cannabis Control Act. The Illinois State Police followed up with two communications for law enforcement.One reads as follows:"This message was released via LEADS, please share with Chiefs:"The Illinois State Police would like to remind officers that any civil violation of the Cannabis Control Act or Drug Paraphernalia Act is NOT reportable to the Bureau of Identification as an arrest offense via live scan or the fingerprint card.Officers may consult 20 ILCS 2630/5 for more detailed information on what offenses are reportable or non-reportable to the Illinois State Police."The other communication wasin the form of "Shift Briefing" for ISP personnel. Local police departments will benefit from the direction provided by ISP. A link to the ISP Shift Briefing is here. What is changing?1. The statutory level of offenses for the possession of cannabis and drug paraphernalia are reduced or decriminalized.2. The Illinois Vehicle Code (625 ILCS 5/11-501 (a)(6)) is amended to specifically exclude (only) cannabis from the trace amount DUI law for ALL drivers.3. The eligibility for Medical Marijuana Patient Cards is amended in light of the reduced statutory levels.4. There is a new offense for the Use of Cannabis Based Product Manufacturing Equipment, which is a Class 2 Felony.5. Certain law enforcement records related to cannabis and drug paraphernalia are subject to automatic expungement.6. The confidential
View More Past Articles: